(Q33342389)

English

Phase I study of JM-216 (an oral platinum analogue) in combination with paclitaxel in patients with advanced malignancies

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Phase I study of JM-216 (an oral platinum analogue) in combination with paclitaxel in patients with advanced malignancies (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

John D Hainsworth

2

object named as

John Hainsworth

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Suzanne Jones

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Howard A Burris

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dana Thompson

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Eric Raefsky

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Valerie Johnson

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sharon Calvert

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Cecile Bulanhagui

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

David Lebwohl

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

F Anthony Greco

10

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

1 February 2002

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Investigational New Drugs

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

55-61

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Phase II study of oral platinum drug JM216 as first-line treatment in patients with small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12008664

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One-hour paclitaxel infusions: review of safety and efficacy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12008664

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of patients with transitional-cell carcinoma of the urothelial tract with ifosfamide, paclitaxel, and cisplatin: a phase II trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/12008664

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I and pharmacokinetic study of an oral platinum complex given daily for 5 days in patients with cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12008664

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12008664

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus

1 reference

https://pubmed.ncbi.nlm.nih.gov/12008664

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One-hour paclitaxel plus carboplatin in the treatment of advanced non-small cell lung cancer: results of a multicentre, phase II trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/12008664

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12008664

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of oral JM216 given twice daily

1 reference

https://pubmed.ncbi.nlm.nih.gov/12008664

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/A:1014473930546

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33342389&oldid=2195263270"